CJ Cheil Jedang, RaQualia join hands for acid pump antagonist
Published: 2010-09-08 06:58:00
Updated: 2010-09-08 06:58:00
CJ Cheil Jedang said on September 3 that it has signed a licensing agreement with RaQualia Pharma Inc, a Japanese pharmaceutical venture, granting CJ exclusive rights to RaQualia’s acid pump Antagonists (RQ-00000004, RQ-00000774).
Under the terms of the agreement, CJ will have a marketing righ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
